238 related articles for article (PubMed ID: 12861143)
1. Short-term urogenital effects of raloxifene, tamoxifen, and estrogen.
Vardy MD; Lindsay R; Scotti RJ; Mikhail M; Richart RM; Nieves J; Zion M; Cosman F
Am J Obstet Gynecol; 2003 Jul; 189(1):81-8. PubMed ID: 12861143
[TBL] [Abstract][Full Text] [Related]
2. Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women.
Ismail SI; Bain C; Hagen S
Cochrane Database Syst Rev; 2010 Sep; (9):CD007063. PubMed ID: 20824855
[TBL] [Abstract][Full Text] [Related]
3. Effects of preoperative intravaginal estrogen on pelvic floor disorder symptoms in postmenopausal women with pelvic organ prolapse.
Rahn DD; Richter HE; Sung VW; Hynan LS; Pruszynski JE
Am J Obstet Gynecol; 2023 Sep; 229(3):309.e1-309.e10. PubMed ID: 37244454
[TBL] [Abstract][Full Text] [Related]
4. Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: a placebo-controlled randomized trial.
Strickler R; Stovall DW; Merritt D; Shen W; Wong M; Silfen SL
Obstet Gynecol; 2000 Sep; 96(3):359-65. PubMed ID: 10960626
[TBL] [Abstract][Full Text] [Related]
5. Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition.
Espeland MA; Shumaker SA; Limacher M; Rapp SR; Bevers TB; Barad DH; Coker LH; Gaussoin SA; Stefanick ML; Lane DS; Maki PM; Resnick SM
J Womens Health (Larchmt); 2010 Mar; 19(3):371-9. PubMed ID: 20136553
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens.
Mijatovic V; van der Mooren MJ; Kenemans P; de Valk-de Roo GW; Netelenbos C
Menopause; 1999; 6(2):134-7. PubMed ID: 10374220
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women.
Mijatovic V; Netelenbos C; van der Mooren MJ; de Valk-de Roo GW; Jakobs C; Kenemans P
Fertil Steril; 1998 Dec; 70(6):1085-9. PubMed ID: 9848300
[TBL] [Abstract][Full Text] [Related]
8. Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.
Parsons A; Merritt D; Rosen A; Heath H; Siddhanti S; Plouffe L;
Obstet Gynecol; 2003 Feb; 101(2):346-52. PubMed ID: 12576260
[TBL] [Abstract][Full Text] [Related]
9. Neither long-term treatment with raloxifene nor hormone replacement therapy modulate cardiac function in healthy postmenopausal women: two randomized, placebo-controlled, 2-year studies.
Vogelvang TE; Mijatovic V; Kamp O; Netelenbos JC; Neele SJ; Pines A; Kenemans P; van der Mooren MJ
Am J Obstet Gynecol; 2002 Apr; 186(4):729-36. PubMed ID: 11967499
[TBL] [Abstract][Full Text] [Related]
10. Beyond estrogen: advances in tissue selective estrogen complexes and selective estrogen receptor modulators.
Pinkerton JV; Conner EA
Climacteric; 2019 Apr; 22(2):140-147. PubMed ID: 30895900
[TBL] [Abstract][Full Text] [Related]
11. Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy.
Pinkerton JV; Stanczyk FZ
Menopause; 2014 Mar; 21(3):309-19. PubMed ID: 23777900
[TBL] [Abstract][Full Text] [Related]
12. Effect of raloxifene on activated protein C (APC) resistance in postmenopausal women and on APC resistance and homocysteine levels in elderly men: two randomized placebo-controlled studies.
Duschek EJ; Neele SJ; Thomassen MC; Rosing J; Netelenbos C
Blood Coagul Fibrinolysis; 2004 Oct; 15(8):649-55. PubMed ID: 15613919
[TBL] [Abstract][Full Text] [Related]
13. Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen.
Goldstein SR; Johnson S; Watts NB; Ciaccia AV; Elmerick D; Muram D
Menopause; 2005 Mar; 12(2):160-4. PubMed ID: 15772563
[TBL] [Abstract][Full Text] [Related]
14. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
Kagan R; Williams RS; Pan K; Mirkin S; Pickar JH
Menopause; 2010 Mar; 17(2):281-9. PubMed ID: 19779382
[TBL] [Abstract][Full Text] [Related]
15. Effects of vaginal conjugated equine estrogens and ospemifene on the rat vaginal wall and lower urinary tract.
Maldonado PA; Montoya TI; Acevedo JF; Keller PW; Word RA
Biol Reprod; 2017 Jan; 96(1):81-92. PubMed ID: 28395337
[TBL] [Abstract][Full Text] [Related]
16. Effect of raloxifene on sexual function in postmenopausal women.
Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
Reid IR; Eastell R; Fogelman I; Adachi JD; Rosen A; Netelenbos C; Watts NB; Seeman E; Ciaccia AV; Draper MW
Arch Intern Med; 2004 Apr; 164(8):871-9. PubMed ID: 15111373
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile.
Lobo RA; Pinkerton JV; Gass MLS; Dorin MH; Ronkin S; Pickar JH; Constantine G
Fertil Steril; 2009 Sep; 92(3):1025-1038. PubMed ID: 19635615
[TBL] [Abstract][Full Text] [Related]
19. Effective treatment of vaginal atrophy with isoflavone vaginal gel.
Lima SM; Yamada SS; Reis BF; Postigo S; Galvão da Silva MA; Aoki T
Maturitas; 2013 Mar; 74(3):252-8. PubMed ID: 23312487
[TBL] [Abstract][Full Text] [Related]
20. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
